Illumina Inc. (ILMN)

309.57
NASDAQ : Health Technology
Prev Close 305.20
Day Low/High 302.82 / 310.43
52 Wk Low/High 263.30 / 380.76
Avg Volume 1.21M
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 44.86B
EPS 5.60
P/E Ratio 47.34
Div & Yield N.A. (N.A)
Illumina (ILMN) Marked As Today's Post-Market Laggard

Illumina (ILMN) Marked As Today's Post-Market Laggard

Trade-Ideas LLC identified Illumina (ILMN) as a post-market laggard candidate

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2015

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2015

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2015.

Illumina Signs Multiple Biobank Deals

Illumina Signs Multiple Biobank Deals

Illumina, Inc. (NASDAQ: ILMN) today announced it has signed four separate biobanking deals with Vanderbilt University, University of Colorado at Denver, Partners HealthCare, and Montreal Heart Institute to advance...

'Mad Money' Lightning Round: I'm Buy, Buy, Buying T-Mobile US

'Mad Money' Lightning Round: I'm Buy, Buy, Buying T-Mobile US

Cramer isn't recommending JD.com, is taking a longer-term view on Novavax and is sticking with Celgene.

Jim Cramer's 'Mad Money' Recap: Market 'Trash' Will Make You Money

Jim Cramer's 'Mad Money' Recap: Market 'Trash' Will Make You Money

The markets are seeing huge sector rotations that can only be characterized as panic, says Cramer. Time to slowly buy the best of what investors are tossing out.

Weak On High Volume: Illumina (ILMN)

Weak On High Volume: Illumina (ILMN)

Trade-Ideas LLC identified Illumina (ILMN) as a weak on high relative volume candidate

Dr. Frances Arnold (Photo: Business Wire)

Dr. Frances Arnold (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) today announced that Dr.

SHPG, ILMN And REGN, 3 Drugs Stocks Pushing The Industry Lower

SHPG, ILMN And REGN, 3 Drugs Stocks Pushing The Industry Lower

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Illumina To Announce Fourth Quarter And Fiscal Year 2015 Financial Results On Tuesday, February 2, 2016

Illumina To Announce Fourth Quarter And Fiscal Year 2015 Financial Results On Tuesday, February 2, 2016

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2015 following the close of market on Tuesday, February 2, 2016.

Bio-Rad And Illumina To Co-Develop Comprehensive Solution For Single-Cell Genomics

Bio-Rad And Illumina To Co-Develop Comprehensive Solution For Single-Cell Genomics

Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb) and Illumina, Inc.

Illumina's Infinium XT Array On A 96-Sample BeadChip (Photo: Business Wire)

Illumina's Infinium XT Array On A 96-Sample BeadChip (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN), the global leader in sequencing and array-based technologies, today announced the newest addition to its industry-leading next-generation sequencing (NGS) portfolio with the launch of the...

Illumina (ILMN) Showing Unusual Social Activity Today

Illumina (ILMN) Showing Unusual Social Activity Today

Trade-Ideas LLC identified Illumina (ILMN) as an unusual social activity candidate

Illumina Forms New Company To Enable Early Cancer Detection Via Blood-Based Screening

Illumina Forms New Company To Enable Early Cancer Detection Via Blood-Based Screening

Illumina, Inc. (NASDAQ:ILMN) today announced GRAIL, a new company formed to enable cancer screening from a simple blood test.

Illumina To Host Investor Call On Sunday, January 10, 2016

Illumina To Host Investor Call On Sunday, January 10, 2016

Illumina, Inc. (NASDAQ: ILMN) today announced that it will host an investor call at 3:00 pm Pacific Time (6:00 pm Eastern Time), Sunday, January 10, 2016.

Illumina Files Two Patent Infringement Suits In Europe For Infringement Of Patents For NIPT

Illumina Files Two Patent Infringement Suits In Europe For Infringement Of Patents For NIPT

Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two patent infringement suits in Europe.

Analysts' Actions -- Chipotle, HP, Moody's, Pioneer Natural Resources and More

Analysts' Actions -- Chipotle, HP, Moody's, Pioneer Natural Resources and More

Here are Thursday's top research calls, including downgrades for Chipotle Mexican Grill, Moody's and HP, and an upgrade for Pioneer Natural Resources.

Analysts' Actions -- Hyatt, Hess, Lockheed Martin, Smith & Wesson and More

Analysts' Actions -- Hyatt, Hess, Lockheed Martin, Smith & Wesson and More

Here are Wednesday's top research calls, including an upgrade for Lockheed Martin, and downgrades for Hyatt, Hess and Smith & Wesson.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ILMN Downgrades: ABTL, AEGN, BELFB, BRG, CUZ, EFUT, HES, MGRC, PII, PWX, RMCF, RPXC, SAIC, SCSC, TPC Initiations: MOLG Read on to get TheStreet Quant Ratings' detailed report:

Insider Trading Alert - SOHO, ANTM And ILMN Traded By Insiders

Insider Trading Alert - SOHO, ANTM And ILMN Traded By Insiders

Stocks with insider trader activity include SOHO, ANTM and ILMN

3 Stocks Pulling The Drugs Industry Downward

3 Stocks Pulling The Drugs Industry Downward

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Illumina Becomes #30 Most Shorted Nasdaq 100 Component, Replacing Henry Schein

Illumina Becomes #30 Most Shorted Nasdaq 100 Component, Replacing Henry Schein

The most recent short interest data has been released by the NASDAQ for the 12/15/2015 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina To Webcast Live Presentation At The J.P. Morgan Annual Healthcare Conference

Illumina To Webcast Live Presentation At The J.P. Morgan Annual Healthcare Conference

Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentation at the J.

Illumina (ILMN) Stock is the ‘Chart of the Day’

Illumina (ILMN) Stock is the ‘Chart of the Day’

Illumina (ILMN) stock is Wednesday’s ‘Chart of the Day.’

This Laggard Is Set to Shine

This Laggard Is Set to Shine

Illumina is moving toward higher ground.

Chart of the Week: Illumina

Illumina is moving toward higher ground.

NVO, INCY And ILMN, Pushing Drugs Industry Downward

NVO, INCY And ILMN, Pushing Drugs Industry Downward

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Illumina's Future Looks Very Bright

Illumina's Future Looks Very Bright

Charts show ILMN is close to offering a great profit opportunity.

3 Drugs Stocks Pushing Industry Growth

3 Drugs Stocks Pushing Industry Growth

TheStreet highlights 3 stocks pushing the drugs industry higher today.

BioMérieux And Illumina Announce The Launch Of BioMérieux EpiSeq™, A Revolutionary Next-Generation Sequencing Service For Epidemiological Monitoring Of Bacterial Infections

BioMérieux And Illumina Announce The Launch Of BioMérieux EpiSeq™, A Revolutionary Next-Generation Sequencing Service For Epidemiological Monitoring Of Bacterial Infections

bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina (Nasdaq: ILMN), a world leader in genomics, announce the launch of bioMérieux EpiSeq™, an innovative next-generation sequencing...

Novogene And Illumina To Co-Develop NGS Diagnostic System For Reproductive Health And Oncology Applications

Novogene And Illumina To Co-Develop NGS Diagnostic System For Reproductive Health And Oncology Applications

Novogene, a leading global provider of genomic services and solutions, and Illumina, Inc.

TheStreet Quant Rating: B (Buy)